KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Current Deferred Revenue (2020 - 2025)

Historic Current Deferred Revenue for Hims & Hers Health (HIMS) over the last 6 years, with Q3 2025 value amounting to $118.5 million.

  • Hims & Hers Health's Current Deferred Revenue rose 26806.49% to $118.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.5 million, marking a year-over-year increase of 26806.49%. This contributed to the annual value of $75.3 million for FY2024, which is 87355.49% up from last year.
  • As of Q3 2025, Hims & Hers Health's Current Deferred Revenue stood at $118.5 million, which was up 26806.49% from $98.4 million recorded in Q2 2025.
  • Hims & Hers Health's Current Deferred Revenue's 5-year high stood at $118.5 million during Q3 2025, with a 5-year trough of $624000.0 in Q1 2021.
  • In the last 5 years, Hims & Hers Health's Current Deferred Revenue had a median value of $3.2 million in 2021 and averaged $26.4 million.
  • In the last 5 years, Hims & Hers Health's Current Deferred Revenue plummeted by 5382.69% in 2022 and then soared by 91992.23% in 2024.
  • Quarter analysis of 5 years shows Hims & Hers Health's Current Deferred Revenue stood at $3.2 million in 2021, then tumbled by 53.83% to $1.5 million in 2022, then soared by 425.34% to $7.7 million in 2023, then surged by 873.55% to $75.3 million in 2024, then soared by 57.35% to $118.5 million in 2025.
  • Its last three reported values are $118.5 million in Q3 2025, $98.4 million for Q2 2025, and $110.8 million during Q1 2025.